Adamis Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Adamis Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 115% to $4,756,078. The net income raised on -$26,199,406 and profit margin reached -551%. Total operating expenses were $23,627,558.
Profit Margin
| 2013 | 0 | -7.19M | |
|---|---|---|---|
| 2014 | 0 | -8.15M | |
| 2015 | 0 | -13.57M | |
| 2016 | 6.47M | -19.43M | -300.24% |
| 2017 | 13.07M | -25.53M | -195.35% |
| 2018 | 15.08M | -39.00M | -258.55% |
| 2019 | 22.11M | -29.30M | -132.53% |
| 2020 | 16.52M | -49.39M | -298.84% |
| 2021 | 2.20M | -34.60M | -1566.56% |
| 2022 | 4.75M | -26.19M | -550.86% |
ADMP Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.75M | 2.20M | 16.52M | 22.11M | 15.08M | 13.07M | 6.47M | 0 | 0 | 0 |
Cost of revenue | 6.18M | 6.87M | 14.89M | 15.47M | 9.79M | 7.41M | 4.85M | 0 | 0 | 0 |
Gross profit | -1.43M | -4.66M | 1.63M | 6.63M | 5.28M | 5.65M | 1.62M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 10.37M | 11.26M | 8.28M | 10.37M | 18.79M | 7.52M | 9.69M | 4.84M | 1.00M | 1.20M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 23.62M | 27.40M | 38.86M | 35.66M | 44.74M | 30.34M | 26.82M | 13.85M | 4.39M | 3.21M |
Operating income | -25.05M | -32.06M | -37.22M | -29.02M | -39.46M | -24.78M | -25.20M | -13.85M | -4.39M | -3.21M |
Other income (expenses), net | -1.13M | -2.53M | 389.38K | -269.59K | -10.51K | -1.08M | 1.39M | 278.43K | -3.76M | -1.51M |
Income before tax | -26.19M | -34.59M | -49.38M | -29.29M | -39.37M | -25.87M | -24.01M | -13.57M | -8.15M | -7.06M |
Income tax expense | 2K | 796 | 2.17K | 8.67K | -369.34K | -339.39K | -4.57M | 0 | 8.62M | 130K |
Net income | -26.19M | -34.60M | -49.39M | -29.30M | -39.00M | -25.53M | -19.43M | -13.57M | -8.15M | -7.19M |
Earnings per share | ||||||||||
Basic EPS | -12.24 | -16.8 | -44.57 | -38.52 | -69.86 | -63.06 | -77.75 | -71.56 | -77.72 | -85.96 |
Diluted EPS | -12.24 | -16.8 | -44.57 | -38.52 | -69.86 | -63.06 | -77.75 | -70.71 | -76.19 | -85.96 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |